They have the 122000sq ft former GMP facility which is a pharma grade facility as you can see in the deal! The option is for the purchase of the greenhouse with a 3.4 million sq foot foot print. Heritage owns the former GMP Facility. (THE ONLY THING UGLY ARE YOUR LYING POST BOBGREENFIELD!) LMFAO LOOSER
(TheNewswire)
Vancouver, B.C. / TheNewswire / October 19, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is pleased to announce that it has executed a Definitive Agreement to acquire CannaCure Corporation (“CannaCure”).
As per the Letter of Intent, previously announced on July 23, 2018, Heritage has acquired 100% of the shares of CannaCure for $40,000,000 in an all-share transaction at a price of $0.30 per share, representing 133,333,333 shares of the Company. Certain significant shareholders are subject to a staged release process in accordance with regulatory standards. CannaCure shareholders will now represent 39.5% of the issued and outstanding shares of Heritage. This transaction does not represent a Change of Control.
CannaCure, based in Fort Erie, Ontario, is a license holder under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It has a 122,000 square foot, former GMP facility, and has completed a 24,260 square foot Phase one build out. CannaCure also has an option to acquire an operational greenhouse with a footprint of 3.4 million square feet. Heritage will continue the conversion of the former GMP facility in a multi-phase approach to accommodate the expected growth in the Company’s extraction business and to meet the demands of the consumables market when approved by Health Canada.
“This is a significant milestone for our company with our growth and expanded footprint” states Clint Sharples, Chairman and interim CEO of Heritage “we believe this cornerstone asset uniquely positions us to expand our potential extraction business across Canada, satisfy potential targeted partnerships, and ensure we have flexible space and capacity to evolve with a rapidly growing market environment.”
An advisory fee of 3% is due and payable in conjunction with the close of this transaction to an arms length advisor.